GGrantIndex
Sort

16,300 grants matching fatty liver disease

FASEB SRC on Growth Hormone/Prolactin Family in Biology & Disease

$4,000
Rhonda D. Kineman · Federation Of Amer Soc For Exper Biology · R13 · FY2019 · DK

FASEB's "The Lipid Droplets Conference"

$4,000
Robert V Farese · Federation Of Amer Soc For Exper Biology · R13 · FY2020 · DK

Role of the Acetyl-CoA Carboxylases in Energy Metabolism

$3,916
Salih Wakil · Baylor College Of Medicine · R01 · FY2011 · GM

METHIONINE METABOLISM IN NON-ALCOHOLIC FATTY LIVER DISEASE

$3,909
John Michael Edmison · Cleveland Clinic Lerner Com-Cwru · M01 · FY2007 · RR

COLLECTION AND BANKING OF BIOLOGICAL SPECIMENS

$3,899
Thomas Harris Inge · Cincinnati Childrens Hosp Med Ctr · M01 · FY2007 · RR

Role of the Acetyl-CoA Carboxylases in Energy Metabolism

$3,899
Salih Wakil · Baylor College Of Medicine · R01 · FY2007 · GM

INSULIN RESISTANCE IN NONALCOHOLIC FATTY LIVER DISEASE A CASE CONTROL STUDY

$3,751
Manal F. Abdelmalek · University Of Florida · M01 · FY2007 · RR

Metabolic abnormalities in non-alcoholic steatohepatitis

$3,738
Indiana Univ-Purdue Univ At Indianapolis · M01 · FY2004 · RR

Nutrigenetic Intervention to Reduce Liver Fat in Hispanics

$3,708
Michael I Goran · University Of Southern California · R01 · FY2019 · MD

Anti-inflammatory actions of a novel hemin-induced electrophile in Sickle Cell Disease

$3,706
Dario A Vitturi · University Of Pittsburgh At Pittsburgh · R03 · FY2022 · HL

TREATMENT OF NONALCOHOLIC LIVER DISEASE IN CHILDREN (TONIC)

$3,655
Karen F Murray · University Of Washington · M01 · FY2007 · RR

ADOLESCENT BARIATRICS

$3,641
Thomas Harris Inge · Cincinnati Childrens Hosp Med Ctr · M01 · FY2008 · RR

Conserved Fetal Epigenomic Signatures in a Primate Model of Maternal Obesity

$3,631
Kjersti Marie Aagaard-Tillery · Baylor College Of Medicine · R01 · FY2013 · DK

Pathophysiological Mechanisms in Major Depression and Bipolar Disorder

$3,590
Philip W Gold · National Institute Of Mental Health · ZIA · FY2014 · MH

IDENTIFICATION OF THE PHYSIOLOGICALLY RELEVANT ENDOGENOUS LIGAND FOR PPAR?

$3,495
Manu V. Chakravarthy · Washington University · P41 · FY2009 · RR

Diabetes & Women's Health Study: long term health implications of GDM

$3,478
Edwina Yeung · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2022 · HD

Signaling and Biotechology Program

$3,396
Hui-Kuan Lin · Wake Forest University Health Sciences · P30 · FY2019 · CA

SILYMARIN (LEGALON<) IN NON-CIRRHOTIC SUBJECTS WITH CHRONIC HEP C

$3,376
Roy L Hawke · Univ Of North Carolina Chapel Hill · M01 · FY2007 · RR

THE RELATIONSHIP OF HEPATIC STEATOSIS TO ENDOTHELIAL DYSFUNCTION IN PATIENTS

$2,912
Richard K. Sterling · Virginia Commonwealth University · M01 · FY2010 · RR

Iron Deficiency and Adversity in Early Life and Cardiometabolic Risk in Adulthood

$2,844
Jenalee Rae Doom · University Of Michigan At Ann Arbor · F32 · FY2017 · HD

GASTRIC BYPASS SURGERY IMPROVES METABOLIC AND HEPATIC ABNORMALITIES

$2,824
Samuel Klein · Washington University · P41 · FY2007 · RR

INSULIN SENSITIVITY AND HEPATIC STEATOSIS IN HEPATITIS C

$2,712
Charles F Burant · University Of Michigan At Ann Arbor · M01 · FY2007 · RR

CVD in American Indians The Dakota Field Center

$2,589
Stacey Jolly · Missouri Breaks Research, Inc. · R01 · FY2017 · HL

Pilot and Feasibility Program

$2,521
David A Shafritz · Albert Einstein College Of Medicine · P30 · FY2012 · DK

INSULIN RESISTANCE IN NON-ALCOHOLIC STEATOHEPATITIS

$2,510
Kristina Marie Utzschneider · University Of Washington · M01 · FY2007 · RR